Audio updated on April 1, 2026, for Apple device compatibility. This article has been edited for brevity and readability.
Learn what the Atherogenic Index of Plasma, or AIP, reveals about hidden cardiometabolic risk—and how to calculate and interpret it using your own triglyceride and HDL values.
🎧 ▶️ Press the play button below to listen in English.
🇨🇳 中文（简体）
🇪🇸 Spanish (Latinoamérica)
Introduction
Most people believe that cholesterol alone determines heart disease risk. If your LDL (low-density lipoprotein) looks “normal,” you are often told you are in the clear. Yet, many heart attacks occur in individuals with acceptable LDL levels.
This is where the atherogenic index becomes important. It is a simple calculation that reveals how damaging your lipid pattern may be—especially in people with insulin resistance, prediabetes, or normal-looking cholesterol panels that hide real risk. It reflects how cholesterol behaves, not just how much of it is present.
What Is the Atherogenic Index?
The term “atherogenic index” commonly refers to the Atherogenic Index of Plasma (AIP) . It is calculated using two standard lipid markers:
AIP = log₁₀ (Triglycerides ÷ HDL cholesterol)
(Using values expressed in mmol/L)
This index captures the balance between triglycerides and HDL—two markers strongly linked to metabolic health. High triglycerides combined with low HDL signal a lipid environment that promotes plaque formation.
Unlike LDL alone, the atherogenic index reflects lipoprotein quality, including particle size and density.
Why the Atherogenic Index Matters More Than LDL Alone
LDL cholesterol measures how much cholesterol is carried in LDL particles, but it does not describe how those particles behave. Two people with the same LDL level can have very different cardiovascular risk depending on particle size, triglyceride burden, and insulin resistance.
The atherogenic index fills this gap. By incorporating both triglycerides and HDL into a logarithmic ratio, it reflects the atherogenic environment of the bloodstream, not just cholesterol quantity.
A 2021 meta-analysis found that higher AIP values were independently associated with significantly greater odds of coronary artery disease across multiple adult populations. When analyzed as a continuous variable, each standard deviation increase in AIP was associated with more than a doubling of the risk of coronary artery disease.
Key takeaway: Normal LDL does not guarantee low risk. A high atherogenic index often signals small, dense LDL particles and underlying insulin resistance—features LDL alone cannot detect.
Atherogenic Index vs Triglyceride/HDL Ratio: Are They Saying the Same Thing?
A common question is whether AIP adds information beyond the simpler triglyceride-to-HDL ratio.
- Triglyceride/HDL ratio: A simple arithmetic relationship. It is easy to calculate, intuitive, and strongly linked to insulin resistance. It serves as an excellent screening marker.
- Atherogenic Index of Plasma (AIP): Takes the same ratio and applies a logarithmic transformation. This reduces distortion caused by extreme triglyceride values and improves correlation with LDL particle size, particularly regarding the presence of small, dense LDL particles.
In practical terms:
- The triglyceride/HDL ratio is ideal for quick metabolic insight and patient education.
- AIP provides a more precise reflection of arterial risk.
Both markers usually move in the same direction. When the triglyceride/HDL ratio is high, AIP is almost always elevated as well. The difference is that AIP more accurately captures the extent to which the lipid pattern may be damaging at the arterial level.
How to Interpret Your Atherogenic Index
Although cutoffs vary slightly across studies, these ranges are commonly used:
- Below 0.11 – Lower cardiovascular risk
- 0.11 to 0.21 – Intermediate risk
- Above 0.21 – Higher atherogenic risk
A higher value suggests a metabolic environment that favors atherosclerosis, even if total cholesterol or LDL appear acceptable.
Important note on units: AIP is always defined using triglyceride and HDL values expressed in mmol/L. If your lab reports values in mg/dL, they must be converted to mmol/L first. Once converted, the interpretation thresholds above apply universally—regardless of the original units.
A Practical Example
Two people may have the same LDL level.
- Person A: Triglycerides 90 mg/dL, HDL 65 mg/dL
- Person B: Triglycerides 190 mg/dL, HDL 38 mg/dL
Person B will almost always have a much higher atherogenic index, reflecting worse lipid quality and higher cardiovascular risk—despite having an LDL level identical to Person A.
Atherogenic Index (AIP) Calculator
Calculates AIP = log10(Triglycerides ÷ HDL) using mmol/L internally.
What Raises the Atherogenic Index?
Several factors drive AIP upward:
- Insulin Resistance
Increases triglyceride production and suppresses HDL formation. This is one of the strongest drivers. - High Sugar and Refined Carbohydrates
Sugar, white flour, and sweetened beverages rapidly raise triglycerides—especially after meals. - Excess Alcohol
Alcohol increases hepatic triglyceride synthesis. Even moderate daily intake can significantly raise triglycerides in susceptible individuals. - Visceral Fat
Abdominal fat releases free fatty acids into the liver, fueling triglyceride overproduction. - Physical Inactivity
Muscle tissue is a major sink for triglycerides. Low muscle mass and inactivity reduce triglyceride clearance.
Why the Atherogenic Index Is Closely Linked to Blood Sugar
The atherogenic index is not just a lipid marker—it is a metabolic marker.
High postprandial (after-meal) blood sugar leads to:
- Increased insulin secretion
- Increased triglyceride synthesis
- Suppressed HDL formation
- More small, dense LDL particles
This explains why AIP often tracks closely with markers like triglyceride-to-HDL ratio, the TyG index (triglyceride-glucose index), fatty liver, and prediabetes.
How to Improve the Atherogenic Index
1. Lower Triglycerides First
Lowering triglycerides has the largest impact on the index.
Effective strategies include:
- Reducing sugar and refined carbohydrates
- Avoiding liquid calories (sugary drinks, excess alcohol)
- Improving post-meal glucose control
- Losing visceral fat
Even modest reductions in triglycerides can dramatically improve AIP.
2. Improve HDL Function (Not Just the Number)
HDL is more than a cholesterol number. It reflects reverse cholesterol transport and anti-inflammatory activity.
Ways to improve HDL function include:
- Regular physical activity and resistance training
- Weight loss around the waist
- Adequate sleep
- Reducing chronic inflammation
Raising HDL artificially without addressing insulin resistance rarely improves outcomes.
The Role of Exercise
Exercise improves AIP through multiple pathways:
- Increases muscle-mediated triglyceride uptake
- Improves insulin sensitivity
- Enhances HDL function
- Reduces visceral fat
The most effective approach combines:
- Resistance training to build muscle
- Zone 2 aerobic exercise to improve fat oxidation
Consistency matters more than intensity. Even moderate daily movement lowers triglycerides over time.
Diet Patterns That Lower the Atherogenic Index
Diets that reliably improve AIP share common features:
- Low added sugar
- Low refined carbohydrates
- Adequate protein
- Whole, minimally processed foods
- Emphasis on post-meal glucose control
This is why Mediterranean-style and lower-carbohydrate approaches often outperform low-fat diets in reducing triglycerides.
Medications, Supplements, and What to Know
Some medications lower LDL without meaningfully improving the atherogenic index. This explains why cardiovascular risk sometimes remains elevated despite treatment.
Supplements may help modestly, but none replace lifestyle change. Lowering triglycerides through metabolic improvement is the most reliable approach.
Atherogenic Index vs. Other Lipid Markers
AIP works best in combination with other markers:
- LDL-C shows cholesterol quantity
- Non-HDL cholesterol captures total atherogenic burden
- ApoB reflects particle number
- Atherogenic index reflects particle quality
Together, they provide a far clearer picture of cardiovascular risk than any single value alone.
Who Should Pay Special Attention?
This index is especially useful for:
- People with prediabetes or type 2 diabetes
- Those with fatty liver disease
- Individuals with “normal” LDL but a family history of heart disease
- People with central obesity
- Those with unexplained cardiovascular events
It often identifies risk years before disease becomes clinically obvious.
Key Takeaways
- The atherogenic index (AIP) reflects how harmful your lipid profile really is.
- It often reveals risk missed by LDL alone.
- High values usually signal insulin resistance and poor post-meal glucose control.
- Lowering triglycerides and improving metabolic health improves the index.
- Exercise and sugar reduction are the most powerful tools.
If you want to prevent heart disease rather than react to it, the atherogenic index is one of the most practical and revealing markers available.
Frequently Asked Questions
What is a normal atherogenic index?
An atherogenic index below 0.11 is generally considered low risk. Values between 0.11 and 0.21 indicate intermediate risk, whereas values above 0.21 are associated with higher cardiovascular and metabolic risk.
Can my LDL be normal but my atherogenic index be high?
Yes. This is common. LDL measures how much cholesterol you carry, but the atherogenic index reflects lipid particle quality, especially the presence of small dense LDL particles, which are more damaging to arteries.
Is the atherogenic index linked to blood sugar?
Strongly. A high atherogenic index is often a sign of insulin resistance, poor post-meal glucose control, or metabolic syndrome—even in people without diagnosed diabetes.
How do I lower my atherogenic index naturally?
The most effective strategies are:
Lowering triglycerides by reducing sugar and refined carbohydrates
Improving post-meal blood sugar control
Exercising regularly, especially resistance and aerobic training
Reducing abdominal fat
Limiting alcohol
Is the atherogenic index better than LDL cholesterol?
It is more informative, not a replacement. LDL shows cholesterol quantity, while the atherogenic index reflects how dangerous the lipid pattern is. Using both together gives a clearer risk picture.
Do cholesterol medications lower the atherogenic index?
Some medications lower LDL without significantly improving the atherogenic index. Improving insulin sensitivity and triglyceride metabolism is often more effective for lowering the index.
Don’t Get Sick!
Medically Reviewed by Dr. Jesse Santiano, MD
Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.
💡 Support This Work
Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.
🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!
Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.
Related:
- Small Dense LDL: What It Means And How To Improve It
- ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
- LDL Particle Number Explained: A Better Marker Than LDL Cholesterol
- TG/HDL Ratio Explained: What It Means and How to Improve It
- HDL Function Explained: Good vs Bad HDL
- High Triglycerides: Causes, Dangers, And How To Lower
- Metabolic Health Check: Your Metabolic Digest (What It Means + How to Improve It)
- New Science Debunks the Dangers of Saturated Fats on Heart Disease
- Machine Learning Finds Your Hidden Heart Disease Risks
- ApoB Reveals Hidden Heart Disease And Diabetes Risk Early
- How to Interpret ApoB and ApoA1 Results
- ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
- CAC And CTA Scans Help Detect Heart Disease Early
- ApoB and ApoA1 Best Predict Heart Attack: How To Get Tested
- ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
- Heart Attack Risk? Use The Framingham Risk Calculator And Lower It Now!
- Discover Your Cardiac Age with This Free Calculator
- Heart Rate Recovery Reveals Hidden Secrets About Your Heart
- Drink Coffee At This Time To Slash Heart Attack Risk
- The FODMAP Trap That Mimics Heart Attacks During Exercise
- The Hidden Link Between High Blood Sugar and Heart Attacks
- Strep From the Mouth and Blood and Sudden Cardiac Death — What You Need to Know
- Lithium’s Hidden Power: Unlocking Protection Against Cardiovascular Disease
- How Reduced Blood Sugar Lowers BP And Cardiovascular Risks
- Cholesterol and Blood Sugar: The Strong Link
References:
- Dobiasova, M. “Atherogenic Index of Plasma [log(triglycerides/HDL-cholesterol)]: Theoretical and Practical Implications.” Clinical Chemistry, vol. 50, no. 7, 2004, pp. 1113–1115.
https://pubmed.ncbi.nlm.nih.gov/15229146/ - Dobiasova, M., and J. Frohlich. “The Plasma Parameter log(TG/HDL-C) as an Atherogenic Index: Correlation with Lipoprotein Particle Size and Esterification Rate in ApoB-Lipoprotein-Depleted Plasma.” Clinical Biochemistry, vol. 34, no. 7, 2001, pp. 583–588.
https://pubmed.ncbi.nlm.nih.gov/11738396/ - Frohlich, J., and M. Dobiasova. “Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography.” Clinical Chemistry, vol. 49, no. 11, 2003, pp. 1873–1880. https://pubmed.ncbi.nlm.nih.gov/14578319/
- da Luz, P. L., et al. “High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease.” Clinical Cardiology, vol. 31, no. 8, 2008, pp. 386–390. https://pmc.ncbi.nlm.nih.gov/articles/PMC2664115/
- Wu J, Zhou Q, Wei Z, Wei J, Cui M. Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis. Front Cardiovasc Med. 2021 Dec 16;8:817441. doi: 10.3389/fcvm.2021.817441. Erratum in: Front Cardiovasc Med. 2023 Mar 08;10:1153914. doi: 10.3389/fcvm.2023.1153914. PMID: 34977202; PMCID: PMC8716758. https://pubmed.ncbi.nlm.nih.gov/34977202/
- Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019 Jul;50(5):285-294. doi: 10.1016/j.arcmed.2019.08.009. Epub 2019 Oct 5. PMID: 31593853. https://pubmed.ncbi.nlm.nih.gov/31593853/
Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.
© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases
Discover more from Don't Get Sick!
Subscribe to get the latest posts sent to your email.